: A top watch for late 2017, it rose 177.7% in just the first half of November. Professional Recommendations (circa 2017)
: Frequently cited as a top "marijuana" buy due to its FDA-track medical developments, though not a traditional penny stock. best penny pot stocks to buy 2017
: Gained 7,100% in the first half of the year, reaching $0.18. : A top watch for late 2017, it rose 177
: Rose 247% in 2017 and was considered a safer alternative to true micro-cap penny stocks. : Rose 247% in 2017 and was considered
During 2017, the "best" penny pot stocks were typically defined by high volatility and massive percentage gains driven by speculation surrounding Canada's 2018 legalization. While these stocks saw astronomical climbs, they were highly speculative and often traded on over-the-counter (OTC) markets with limited financial transparency.
: Recorded a staggering 7,150% gain by August 2017, rising from $0.02 to $1.45.
: Highlighted for its potential in cannabinoid-focused biotech.